INVO Fertility, Inc. (IVF)

INVO Fertility Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023
Net Income	-28.96	-9.1	-8.03
Depreciation & Amortization	0.77	0.92	0.2
Other Amortization	0.22	0.62	0.72
Loss (Gain) From Sale of Assets	1.53	0.51	-
Loss (Gain) From Sale of Investments	-	-	0.09
Loss (Gain) on Equity Investments	-0.03	-0.01	0.06
Stock-Based Compensation	1.59	1.77	1.57
Other Operating Activities	0.45	0.44	0.16
Change in Accounts Receivable	-0.02	-0.03	-0.06
Change in Inventory	0.05	0.04	-0
Change in Accounts Payable	0.62	1.35	0.92
Change in Unearned Revenue	0.16	0.19	0.29
Change in Other Net Operating Assets	-0.1	0.31	-0.68
Operating Cash Flow	-7.66	-2.97	-4.76
Capital Expenditures	-0.11	-0.18	-0.44
Sale of Property, Plant & Equipment	-	0.08	-
Cash Acquisitions	0.47	0.47	-2.04
Investment in Securities	-	-	-0.01
Investing Cash Flow	0.35	0.36	-2.49
Short-Term Debt Issued	-	-	0.1
Long-Term Debt Issued	-	1.34	3.06
Total Debt Issued	0.65	1.34	3.16
Long-Term Debt Repaid	-	-0.93	-1.5
Net Debt Issued (Repaid)	-0.76	0.41	1.66
Issuance of Common Stock	9.79	1.07	5.73
Financing Cash Flow	7.19	3.12	7.39
Net Cash Flow	-0.12	0.51	0.14
Free Cash Flow	-7.77	-3.16	-5.2
Free Cash Flow Margin	-111.86%	-48.35%	-172.14%
Free Cash Flow Per Share	-56.54	-244.87	-
Cash Interest Paid	0.42	0.21	0.01
Levered Free Cash Flow	0.95	3.2	-
Unlevered Free Cash Flow	1.3	3.24	-
Change in Working Capital	0.71	1.86	0.47

Updated Nov 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q